Ginkgo Bioworks
YC S14Boston, US · Founded 2009 · 641 employees · Public · 5 known investors
Ginkgo Bioworks develops autonomous laboratory systems that automate manual benchwork in biotechnology R&D, enabling scientists to conduct experiments through natural language requests rather than manual lab work.
AI & Machine LearningBiotechDeep TechHealthtechSynthetic BiologyDiagnosticsAutomationin /ginkgo-bioworks/@Ginkgo
Founders & leadership· Y Combinator alumni (S14)
Investors · 5
In the news
- What Does Ginkgo Bioworks' Strategic Pivot Mean for Investorskavout.com · 2026
- Exclusive: Google Cloud And Ginkgo Bioworks Partner To Launch New Protein LLM and APIforbes.com · 2024
- Ginkgo Is Trying to Detect Future Man-Made Biological Threatsbloomberg.com · 2022
- How an Airport Nail Salon Became the Frontline of US Covid Surveillancebloomberg.com · 2022
- Synthetic biology pioneer Ginkgo Bioworks goes publicaxios.com · 2021
- Ginkgo Bioworks - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2021
- Ginkgo Bioworks raises $350 mln fund for biotech spinouts | Financial Postfinancialpost.com · 2019
- Ginkgo Bioworks Raises $275m Series D for Robotic Microbe Factory Expansion - AgFunderNewsagfundernews.com · 2017